LTZ Therapeutics

LTZ Therapeutics is a globally leading biotechnology company that develops novel immunotherapies targeting cancer and other complex diseases with significant unmet clinical needs, systematically enhancing patient clinical outcomes. The company’s international team is located in Shenzhen, China; Palo Alto, California, USA; and Heidelberg, Germany. Based on reverse translational science and emerging tumor microenvironment biology, LTZ Therapeutics is committed to developing next-generation immunotherapies that not only overcome drug resistance and recurrence but also enhance anti-tumor immunity.